Merck spins off lowgrowth drugs in a purposeful shift of focus

Merck spins off low-growth drugs in a ‘purposeful shift’ of focus

06:36 EST 6 Feb 2020 | PMLIVE

Fourth quarter results overshadowed by spinoff annoucement

Original Article: Merck spins off low-growth drugs in a ‘purposeful shift’ of focus

More From BioPortfolio on "Merck spins off low-growth drugs in a ‘purposeful shift’ of focus"